These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma. Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134 [TBL] [Abstract][Full Text] [Related]
24. Phase II study of mitoxantrone and cytarabine in acute myeloid leukemia. Brito-Babapulle F; Catovsky D; Slocombe G; Newland AC; Marcus RE; Goldman JM; Galton DA Cancer Treat Rep; 1987 Feb; 71(2):161-3. PubMed ID: 3467843 [TBL] [Abstract][Full Text] [Related]
25. Cyclophosphamide/etoposide: effective reinduction therapy for children with acute nonlymphocytic leukemia in relapse. Kalwinsky DK; Dahl GV; Mirro J; Look AT Cancer Treat Rep; 1985; 69(7-8):887-9. PubMed ID: 4016796 [TBL] [Abstract][Full Text] [Related]
26. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol. Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387 [TBL] [Abstract][Full Text] [Related]
27. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology. Early AP; Preisler HD; Slocum H; Rustum YM Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642 [TBL] [Abstract][Full Text] [Related]
28. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Al Bahar S; Pandita R; Bavishi K; Kreze O Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411 [TBL] [Abstract][Full Text] [Related]
29. Usefulness of cytosine arabinoside (NSC-63878) and prednisone (NSC-10023) in refractory childhood lymphoblastic leukemia. Nesbit ME; Sonley M; Hammond D Med Pediatr Oncol; 1976; 2(1):61-8. PubMed ID: 1064743 [TBL] [Abstract][Full Text] [Related]
30. A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial. Vogler WR; McCarley DL; Stagg M; Bartolucci AA; Moore J; Martelo O; Omura GA Leukemia; 1994 Nov; 8(11):1847-53. PubMed ID: 7967730 [TBL] [Abstract][Full Text] [Related]
31. Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM). Hiddemann W; Büchner T; Heil G; Schumacher K; Diedrich H; Maschmeyer G; Ho AD; Planker M; Gerith-Stolzenburg S; Donhuijsen-Ant R Leukemia; 1990 Sep; 4(9):637-40. PubMed ID: 2395383 [TBL] [Abstract][Full Text] [Related]
32. Treatment of childhood acute lymphoblastic leukemia with intermediate-dose cytosine arabinoside and adriamycin. Ishii E; Hara T; Ohkubo K; Matsuzaki A; Takeuchi T; Ueda K Med Pediatr Oncol; 1986; 14(2):73-7. PubMed ID: 3458999 [TBL] [Abstract][Full Text] [Related]
33. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia. Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346 [TBL] [Abstract][Full Text] [Related]
35. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia. Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary complications of cytosine-arabinoside therapy: radiographic findings. Tham RT; Peters WG; de Bruïne FT; Willemze R AJR Am J Roentgenol; 1987 Jul; 149(1):23-7. PubMed ID: 3495987 [TBL] [Abstract][Full Text] [Related]
37. High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia. Lockhart S; Plunkett W; Jeha S; Ramirez I; Zipf T; Cork A; Pinkel D J Clin Oncol; 1994 Mar; 12(3):587-95. PubMed ID: 8120558 [TBL] [Abstract][Full Text] [Related]
38. Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study. Tallman MS; Lee S; Sikic BI; Paietta E; Wiernik PH; Bennett JM; Rowe JM Cancer; 1999 Jan; 85(2):358-67. PubMed ID: 10023703 [TBL] [Abstract][Full Text] [Related]
39. Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia. Karbasian-Esfahani M; Wiernik PH; Novik Y; Paietta E; Dutcher JP Cancer; 2004 Sep; 101(6):1414-9. PubMed ID: 15368329 [TBL] [Abstract][Full Text] [Related]
40. Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide. Kalwinsky D; Mirro J; Schell M; Behm F; Mason C; Dahl GV J Clin Oncol; 1988 Jul; 6(7):1134-43. PubMed ID: 3292713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]